Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

MHUA vs DBVT vs ALKS vs CODA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MHUA
Meihua International Medical Technologies Co., Ltd.

Medical - Instruments & Supplies

HealthcareNASDAQ • CN
Market Cap$2M
5Y Perf.-99.1%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.+56.6%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+21.1%
CODA
Coda Octopus Group, Inc.

Aerospace & Defense

IndustrialsNASDAQ • US
Market Cap$134M
5Y Perf.+129.1%

MHUA vs DBVT vs ALKS vs CODA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MHUA logoMHUA
DBVT logoDBVT
ALKS logoALKS
CODA logoCODA
IndustryMedical - Instruments & SuppliesBiotechnologyBiotechnologyAerospace & Defense
Market Cap$2M$1712.35T$5.90B$134M
Revenue (TTM)$184M$0.00$1.56B$28M
Net Income (TTM)$19M$-168M$153M$4M
Gross Margin33.6%65.4%66.3%
Operating Margin12.6%12.3%17.4%
Forward P/E0.2x24.8x22.5x
Total Debt$8M$22M$70M$395K
Cash & Equiv.$16M$194M$1.12B$29M

MHUA vs DBVT vs ALKS vs CODALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MHUA
DBVT
ALKS
CODA
StockFeb 22Apr 26Return
Meihua Internationa… (MHUA)1000.9-99.1%
DBV Technologies S.… (DBVT)100156.6+56.6%
Alkermes plc (ALKS)100121.1+21.1%
Coda Octopus Group,… (CODA)100229.1+129.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: MHUA vs DBVT vs ALKS vs CODA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CODA leads in 3 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Meihua International Medical Technologies Co., Ltd. is the stronger pick specifically for valuation and capital efficiency and operational efficiency and capital deployment. DBVT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MHUA
Meihua International Medical Technologies Co., Ltd.
The Value Play

MHUA is the #2 pick in this set and the best alternative if value and efficiency is your priority.

  • Lower P/E (0.2x vs 22.5x)
  • 9.7% ROA vs DBVT's -89.0%
Best for: value and efficiency
DBVT
DBV Technologies S.A.
The Income Pick

DBVT is the clearest fit if your priority is income & stability.

  • Dividend streak 0 yrs, beta 1.26
  • +110.4% vs MHUA's -73.6%
Best for: income & stability
ALKS
Alkermes plc
The Quality Angle

ALKS lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
CODA
Coda Octopus Group, Inc.
The Growth Play

CODA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 30.7%, EPS growth 15.6%, 3Y rev CAGR 6.1%
  • 8.4% 10Y total return vs ALKS's -11.0%
  • Lower volatility, beta 1.00, Low D/E 0.7%, current ratio 8.86x
  • Beta 1.00, current ratio 8.86x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCODA logoCODA30.7% revenue growth vs DBVT's -100.0%
ValueMHUA logoMHUALower P/E (0.2x vs 22.5x)
Quality / MarginsCODA logoCODA14.8% margin vs DBVT's 0.3%
Stability / SafetyCODA logoCODABeta 1.00 vs MHUA's 2.86, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs MHUA's -73.6%
Efficiency (ROA)MHUA logoMHUA9.7% ROA vs DBVT's -89.0%

MHUA vs DBVT vs ALKS vs CODA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MHUAMeihua International Medical Technologies Co., Ltd.

Segment breakdown not available.

DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
CODACoda Octopus Group, Inc.
FY 2025
Equipment Sales
71.3%$14M
Service
17.3%$4M
Equipment Rentals
7.3%$1M
Software Sales
4.0%$811,912

MHUA vs DBVT vs ALKS vs CODA — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCODALAGGINGDBVT

Income & Cash Flow (Last 12 Months)

CODA leads this category, winning 4 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. CODA is the more profitable business, keeping 14.8% of every revenue dollar as net income compared to ALKS's 9.8%. On growth, CODA holds the edge at +28.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMHUA logoMHUAMeihua Internatio…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCODA logoCODACoda Octopus Grou…
RevenueTrailing 12 months$184M$0$1.6B$28M
EBITDAEarnings before interest/tax$24M-$112M$212M$6M
Net IncomeAfter-tax profit$19M-$168M$153M$4M
Free Cash FlowCash after capex$12M-$151M$392M$7M
Gross MarginGross profit ÷ Revenue+33.6%+65.4%+66.3%
Operating MarginEBIT ÷ Revenue+12.6%+12.3%+17.4%
Net MarginNet income ÷ Revenue+10.1%+9.8%+14.8%
FCF MarginFCF ÷ Revenue+6.6%+25.1%+24.6%
Rev. Growth (YoY)Latest quarter vs prior year-16.2%+28.2%+28.8%
EPS Growth (YoY)Latest quarter vs prior year-35.8%+91.5%-4.1%+3.0%
CODA leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MHUA leads this category, winning 4 of 5 comparable metrics.

At 0.2x trailing earnings, MHUA trades at a 99% valuation discount to CODA's 32.2x P/E. On an enterprise value basis, ALKS's 17.3x EV/EBITDA is more attractive than CODA's 17.9x.

MetricMHUA logoMHUAMeihua Internatio…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCODA logoCODACoda Octopus Grou…
Market CapShares × price$2M$1712.35T$5.9B$134M
Enterprise ValueMkt cap + debt − cash-$6M$1712.35T$4.9B$106M
Trailing P/EPrice ÷ TTM EPS0.19x-0.76x24.76x32.16x
Forward P/EPrice ÷ next-FY EPS est.22.45x
PEG RatioP/E ÷ EPS growth rate7.51x
EV / EBITDAEnterprise value multiple-0.40x17.25x17.85x
Price / SalesMarket cap ÷ Revenue0.02x4.00x5.05x
Price / BookPrice ÷ Book value/share0.01x0.66x3.28x2.30x
Price / FCFMarket cap ÷ FCF0.14x12.28x22.20x
MHUA leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

MHUA delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-130 for DBVT. CODA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs DBVT's 4/9, reflecting strong financial health.

MetricMHUA logoMHUAMeihua Internatio…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCODA logoCODACoda Octopus Grou…
ROE (TTM)Return on equity+11.2%-130.2%+8.8%+7.2%
ROA (TTM)Return on assets+9.7%-89.0%+5.4%+6.6%
ROICReturn on invested capital+7.4%+18.9%+11.2%
ROCEReturn on capital employed+9.4%-145.7%+14.2%+8.1%
Piotroski ScoreFundamental quality 0–94477
Debt / EquityFinancial leverage0.05x0.13x0.04x0.01x
Net DebtTotal debt minus cash-$8M-$172M-$1.0B-$28M
Cash & Equiv.Liquid assets$16M$194M$1.1B$29M
Total DebtShort + long-term debt$8M$22M$70M$394,932
Interest CoverageEBIT ÷ Interest expense31.87x-189.82x32.30x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CODA leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $59 for MHUA. Over the past 12 months, DBVT leads with a +110.4% total return vs MHUA's -73.6%. The 3-year compound annual growth rate (CAGR) favors CODA at 10.4% vs MHUA's -71.3% — a key indicator of consistent wealth creation.

MetricMHUA logoMHUAMeihua Internatio…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCODA logoCODACoda Octopus Grou…
YTD ReturnYear-to-date+271.2%+4.9%+25.3%+25.1%
1-Year ReturnPast 12 months-73.6%+110.4%+16.5%+78.9%
3-Year ReturnCumulative with dividends-97.6%+19.7%+14.5%+34.5%
5-Year ReturnCumulative with dividends-99.4%-69.1%+60.9%+49.7%
10-Year ReturnCumulative with dividends-99.4%-87.0%-11.0%+844.4%
CAGR (3Y)Annualised 3-year return-71.3%+6.2%+4.6%+10.4%
CODA leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ALKS and CODA each lead in 1 of 2 comparable metrics.

CODA is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than MHUA's 2.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs MHUA's 11.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMHUA logoMHUAMeihua Internatio…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCODA logoCODACoda Octopus Grou…
Beta (5Y)Sensitivity to S&P 5002.86x1.26x1.06x1.00x
52-Week HighHighest price in past year$64.00$26.18$36.60$17.28
52-Week LowLowest price in past year$2.05$7.53$25.17$5.98
% of 52W HighCurrent price vs 52-week peak+11.9%+76.3%+96.7%+68.9%
RSI (14)Momentum oscillator 0–10049.348.160.248.6
Avg Volume (50D)Average daily shares traded1K252K2.3M256K
Evenly matched — ALKS and CODA each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: DBVT as "Buy", ALKS as "Buy", CODA as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 17.6% for CODA (target: $14).

MetricMHUA logoMHUAMeihua Internatio…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCODA logoCODACoda Octopus Grou…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$46.33$44.00$14.00
# AnalystsCovering analysts15281
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises000
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+9.6%0.0%+0.5%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

CODA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MHUA leads in 1 (Valuation Metrics). 1 tied.

Best OverallCoda Octopus Group, Inc. (CODA)Leads 2 of 6 categories
Loading custom metrics...

MHUA vs DBVT vs ALKS vs CODA: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MHUA or DBVT or ALKS or CODA a better buy right now?

For growth investors, Coda Octopus Group, Inc.

(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Meihua International Medical Technologies Co. , Ltd. (MHUA) offers the better valuation at 0. 2x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MHUA or DBVT or ALKS or CODA?

On trailing P/E, Meihua International Medical Technologies Co.

, Ltd. (MHUA) is the cheapest at 0. 2x versus Coda Octopus Group, Inc. at 32. 2x.

03

Which is the better long-term investment — MHUA or DBVT or ALKS or CODA?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -99. 4% for Meihua International Medical Technologies Co. , Ltd. (MHUA). Over 10 years, the gap is even starker: CODA returned +844. 4% versus MHUA's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MHUA or DBVT or ALKS or CODA?

By beta (market sensitivity over 5 years), Coda Octopus Group, Inc.

(CODA) is the lower-risk stock at 1. 00β versus Meihua International Medical Technologies Co. , Ltd. 's 2. 86β — meaning MHUA is approximately 186% more volatile than CODA relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MHUA or DBVT or ALKS or CODA?

By revenue growth (latest reported year), Coda Octopus Group, Inc.

(CODA) is pulling ahead at 30. 7% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Coda Octopus Group, Inc. grew EPS 15. 6% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MHUA or DBVT or ALKS or CODA?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MHUA or DBVT or ALKS or CODA more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

08

Which pays a better dividend — MHUA or DBVT or ALKS or CODA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is MHUA or DBVT or ALKS or CODA better for a retirement portfolio?

For long-horizon retirement investors, Coda Octopus Group, Inc.

(CODA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +844. 4% 10Y return). Meihua International Medical Technologies Co. , Ltd. (MHUA) carries a higher beta of 2. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CODA: +844. 4%, MHUA: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MHUA and DBVT and ALKS and CODA?

These companies operate in different sectors (MHUA (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and CODA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MHUA is a small-cap deep-value stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; CODA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MHUA

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 6%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

CODA

High-Growth Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 8%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.